Epclusa 400 mg (Sofosbuvir TABLET) 400 MG

EPCLUSA 400 MG tablets contain sofosbuvir, a direct-acting antiviral used to treat chronic hepatitis C. This medication is often combined with other treatments for effective results.

Strength

400 MG

Pack Size

Manufacturer / TM Owner

GILEAD SCIENCES CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

EPCLUSA 400 MG tablets are primarily used in the treatment of chronic hepatitis C virus (HCV) infection. Sofosbuvir, the active ingredient, works by inhibiting the HCV NS5B protein, which is essential for viral replication. This medication is often part of a combination therapy to improve treatment outcomes. What is EPCLUSA used for? It is used to manage HCV infections, including different genotypes of the virus.

Side Effects

Common effects of EPCLUSA 400 MG tablets may include fatigue, headache, nausea, and insomnia. Some individuals may experience more severe side effects, and it is important to consult a healthcare provider if any adverse reactions occur. The effects can vary from person to person, and not everyone will experience the same symptoms.

Precautions & Warnings

EPCLUSA 400 MG tablets should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may not be suitable for everyone, especially those with certain medical conditions or allergies. Always inform your healthcare provider about any other medications you are taking.

Avoid Interactions

EPCLUSA 400 MG tablets may interact with other medications, including certain antiviral drugs, HIV medications, and seizure medications. It is crucial to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances may also affect the efficacy and safety of this medication.

Frequently Asked Questions

EPCLUSA 400 MG tablets are used to treat chronic hepatitis C virus (HCV) infection, often in combination with other medications.

EPCLUSA 400 MG tablets are taken orally, typically once daily, as prescribed by a healthcare provider.

Common side effects may include fatigue, headache, nausea, and insomnia. Severe side effects are less common but should be reported to a healthcare provider.

EPCLUSA may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

EPCLUSA may not be suitable for individuals with certain medical conditions or allergies. Always consult a healthcare provider before starting this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.